NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name pantoprazole
Trade Name Protonix
Classification Dose Route Time/frequency antiulcer agents, 40 mg PO daily gastric acid pump inhibitors Duration Normal dosage range 1 wk 40 mg once to twice daily, up to 120 mg twice daily.
Peak Unknown
Onset 2.5 hrs
Why is your patient getting this medication Heartburn
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Binds to an enzyme in the presence of acidic gastric pH, preventing the final transport of hydrogen ions into the gastric lumen. Diminished accumulation of acid in the gastric lumen, with lessened acid reflux, Healing of duodenal ulcers and esophagitis, Decreased acid secretion in hypersecretory conditions. Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None known for this patient.
Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity, do not break chew or crush tablets.
Nursing Process- Assessment (Pre-administration assessment) Assess patient routinely for epigastric or abdominal pain and for frank or occult blood in stool, emesis, or gastric aspirate.
Common side effects No common or life threatening side effects
Lab value alterations caused by medicine May cause abnormal liver function tests, including ↑ AST, ALT, alkaline phosphatase, and bilirubin. Be sure to teach the patient the following about this medication Instruct patient to take medication as directed for the full course of therapy, even if feeling better, Advise patient to avoid alcohol, products containing aspirin or NSAIDs, and foods that may cause an increase in GI irritation, Advise patient to report onset of black, tarry stools; diarrhea; or abdominal pain to health care professional promptly.
Assessment Why would you hold or not give this med? Hypersensitivity, signs of gastric bleeding.
Evaluation Check after giving Healing in patients with erosive esophagitis. Therapy is continued for up to 8 wks.